These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9725046

  • 1. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
    Seike M, Andoh M, Hasegawa K, Sakonji M, Tsuboi E.
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
    Takanashi N, Hara N, Ichinose Y, Asoh H, Yano T, Yokoyama H, Miura T, Matsuoka Y, Tayama K, Ohta M.
    Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761
    [Abstract] [Full Text] [Related]

  • 3. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T, Koga T, Nomiyama H, Hidaka H.
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
    [Abstract] [Full Text] [Related]

  • 4. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
    Gemma A, Kudoh S, Yoshimura A, Ono Y, Takenaka K, Hayashihara K, Hino M, Shibuya M, Niitani H.
    Anticancer Res; 1995 Jul; 15(6B):2691-5. PubMed ID: 8669849
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Takayama K, Kawasaki M, Ninomiya K, Motohiro A, Fujita M, Watanabe K, Kajiki A, Iwami F, Miyazaki N, Izumi M, Hara N, Nakanishi Y, Fukuoka Lung Cancer Study Group, Japan.
    Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE.
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
    Kinoshita T, Akaogi E, Mitsui K, Onizuka M, Ishikawa S, Morita R, Ishibashi O, Suga M, Inagaki M, Okazaki H.
    Gan To Kagaku Ryoho; 1994 May; 21(6):891-4. PubMed ID: 8185351
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.